demonstrated a highly significant survival benefit in SLN-positive patients who had received CLND (5-year survival rate 72%) compared to SLN-positive patients who had received delayed ELND (Elective LND) after clinical detection of lymph node metastasis (5-year survival rate 52%) [ 16 ].
← all excerpts
SLN melanoma micrometastasis predictivity of nodal status: a long term retrospective study.
1
—
—